Bone Biologics (BBLG) vs HeartSciences (HSCS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
HeartSciences is the larger company by market cap ($15.4 million vs $1.3 million), about 12.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BBLG | HSCS |
|---|---|---|
| Share price | $0.4671 | $3.18 |
| Market cap | $1.29M | $15.40M |
| 1-day change | -0.43% | +4.61% |
| YTD return | — | -1.62% |
| 1-year return | — | -18.28% |
| EPS (TTM) | $-1.37 | $-3.21 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.76 | $5.25 |
| 52-week low | $0.428 | $1.63 |
| Distance from 52-week high | -83.07% | -39.43% |
| Analyst consensus | none | buy |
| Avg. price target upside | +2511.86% | +277.36% |
| Average volume | 378.20K | 154.08K |
| Shares outstanding | 2.76M | 4.84M |
| Employees | 2 | 14 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HeartSciences is about 12.0 times larger than Bone Biologics by market value ($15.40M vs $1.29M).
About Bone Biologics
BBLG stock →Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration.
Health Care · Industrial Specialties · 2 employees
About HeartSciences
HSCS stock →HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform.
Health Care · Industrial Specialties · 14 employees
BBLG vs HSCS FAQ
Which is bigger, Bone Biologics or HeartSciences?
HeartSciences (HSCS) is larger, with a market capitalization of $15.40M compared with $1.29M for Bone Biologics (BBLG).
Are Bone Biologics and HeartSciences in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.